PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

Clinical trial NCT06977074 · RECRUITING

Trial details

NCT number: NCT06977074
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2025-05-10
Primary completion: 2028-05-10
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.